Clinical Trials Browser

Completed × UNKNOWN × Bevacizumab × Clear all

NCT04247984 2022-03-11

A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms